Radiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed Gliomas

NCT00100802 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

118

Enrollment

NETWORK

Sponsor class

Conditions

Anaplastic Astrocytoma
Central Nervous System Neoplasm
Glioblastoma
Gliosarcoma
Spinal Cord Neoplasm

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Lomustine
RADIATION: Radiation Therapy
DRUG: Temozolomide

Sponsor

Children's Oncology Group

Collaborators

[object Object]